论文部分内容阅读
干扰能抗病毒治疗的疗效各家报道不一。近年来我们采用磷甲酸钠 (连云港天晴制药厂生产 )与干扰能 (IFNα -2b ,美国Schering生产 )序贯疗法治疗乙型肝炎 18例 ,并与联合应用日达仙 (Tα1,美国Schering生产 )和IFNα- 2b治疗的 12例作对照 ,结果报道
Interference can be antiviral therapy reported different results. In recent years, we use sequential therapy of sodium phosphate (manufactured by Lianyungang TQC) and interferon (IFNα-2b, Schering) to treat 18 cases of hepatitis B, and in combination with the combination of daily dose of Tα1 (Schering, USA) And IFNα-2b treatment of 12 cases as a control, the results reported